ArticleLasers in surgery and medicine2025
Effects of Nonablative Er-YAG Laser on Human Endometrial Stromal Cells (hESCs): A Pilot Study.
Article in Lasers in surgery and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesTo investigate the thermo-chemical effects of nonablative Er:YAG laser on human endometrial stromal cells (hESCs). MATERIALS AND
methodsIn this laboratory based study, for the hESCs cultures, endometrial tissue biopsy samples were obtained from three fertile women in the late proliferative phase. In this laboratory-based study, seven experimental groups were created: Estradiol (E
resultsMedian MMP-2 levels significantly differed between groups at the 12th, 24th, 48th, and 72nd hour (p = 0.012, p = 0.045, p = 0.021, and p = 0.032, respectively). All media of hESCs irradiated with Er-YAG laser had higher median MMP-2 values. At the 48th hour, the groups showed significant differences in terms of median TNF-α levels (p = 0.029), which were lower in the groups that received Er-YAG laser. At the 12th hour, median IL-6 levels differed significantly between the groups (p = 0.011), being higher in the groups that received Er-YAG laser. At the 72nd hour, lower median VEGF-A values were observed for the groups that received Er-YAG laser (p = 0.021). A statistically significant difference existed in terms of median IGFBP-1 levels between the groups at the 24th hour, with higher levels in the groups which received Er-YAG laser (p = 0.041).
conclusionOur findings demonstrated that the non-ablative Er-YAG laser induces tissue remodeling, modulates immune responses by favoring Th2 cell activity and suppresses Th1 cell activity in hESCs. Additionally, it exerts favorable impact on decidualization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.